a 2006

Evaluation of migration-stimulating factor expression for breast cancer diagnosis and prognosis

JONES, S.L., I.R. ELLIS, Kateřina KAŇKOVÁ, A.M. THOMPSON, P. PREECE et. al.

Basic information

Original name

Evaluation of migration-stimulating factor expression for breast cancer diagnosis and prognosis

Name in Czech

Hodnocení exprese migration-stimulating factor ve vztahu k diagnostice a prognóze nádorů prsu

Authors

JONES, S.L. (826 United Kingdom of Great Britain and Northern Ireland), I.R. ELLIS (826 United Kingdom of Great Britain and Northern Ireland), Kateřina KAŇKOVÁ (203 Czech Republic, guarantor), A.M. THOMPSON (826 United Kingdom of Great Britain and Northern Ireland), P. PREECE (826 United Kingdom of Great Britain and Northern Ireland), S. KAZMI (826 United Kingdom of Great Britain and Northern Ireland), S.L. SCHOR (826 United Kingdom of Great Britain and Northern Ireland) and A.M. SCHOR (826 United Kingdom of Great Britain and Northern Ireland)

Edition

2006

Other information

Language

English

Type of outcome

Konferenční abstrakt

Field of Study

30200 3.2 Clinical medicine

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

RIV identification code

RIV/00216224:14110/06:00017322

Organization unit

Faculty of Medicine

UT WoS

000241766700030

Keywords in English

breast cancer; MSF; prognosis
Změněno: 2/4/2010 15:12, prof. MUDr. Kateřina Kaňková, Ph.D.

Abstract

V originále

Objective of the project was to evaluate the impact of migration-stimulating factor expression for breast cancer diagnosis and prognosis.

In Czech

Cílem práce bylo zhodnotit význam exprese migration-stimulating factor ve vztahu k diagnostice a prognóze nádorů prsu.

Links

LZ1K03019, research and development project
Name: Zlepšení hojení ran u pacientů s diabetem: preklinické ověření role proteinu MSF
Investor: Ministry of Education, Youth and Sports of the CR